Vivos Therapeutics Inks Distribution Agreement With Dubai-based Sleep Testing Company to Support International Expansion, Expects Revenue From This Collaboration in 2024
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics has signed a distribution agreement with a Dubai-based sleep testing company to support its international expansion. The company expects to generate revenue from this collaboration starting in 2024.
October 05, 2023 | 11:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vivos Therapeutics' new distribution agreement is expected to support its international expansion and generate revenue from 2024.
The distribution agreement with the Dubai-based company is a strategic move for Vivos Therapeutics to expand its international presence. This is expected to increase the company's revenue from 2024, which could positively impact the stock price in the long term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100